Pharma Journalist - Page 890 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Zymeworks Receives Second Orphan Drug Designation for ZW25 in Gastric Cancer

Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya

BioCryst to explore oral liquid formulation of BCX7353 for use in Acute HAE attacks

Novartis to In-Licence ECF843 to Strengthen R&D pipeline

GE and CBMG collaborated to co-develop CAR-T and Stem Cell Manufacturing

GlucoMe Appoints John Erickson as EVP, General Manager North America

Abbott and Alere Amend Terms of Merger Agreement

FDA Allows NuvOx Pharma to Run a Phase II Clinical Trial in Brain Cancer

Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer

Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia